The Lancet criticized India’s combat opposed to the coronavirus outbreak, saying the country had “overstepped the market” to the virus scenario.
The editorial, published in the Lancet magazine, also expressed fear that the Indian Council for Medical Research (ICMR) “will deviate from clinical evidence” to allay fears.
The editorial read: “. . . Presenting the existing scenario in India with too much of a positive spin not only obscures the truth, but also hinders important public fitness initiatives. The perpetuation of unrealistic accusations or not honestly reporting negative news creates uncertainty among the public and physical health professionals discourage others from taking preventive measures or taking public messages about fitness seriously.
“India has experience in medicine, public health, studies and production to lead the country through the Covid-19 pandemic. To take advantage of these attributes, the country’s leaders will have to respect clinical evidence, qualified observation and educational freedom, and not provide false optimism,” he added.
However, the publisher thanked India for its blocking measures launched in March this year, however, the elimination of such strict measures could possibly have resulted in an unprecedented increase in the number of coronavirus cases.
The publisher raised doubts about the quality of coronavirus knowledge in India.
The publisher calls for the role of the ICMR in crisis management, expressed doubts about its recommendations and added the insistence on hydroxychloroquine without any really extensive evidence.
The editorial also the impetus discussed through CIRM CEO Balram Bhargava to purchase the coronavirus vaccine long before the vaccine finished its trials.
“This tension in the face of negative news and peace of mind turns out to have been felt through several pro-clinic organizations in India. The Indian Medical Research Council (ICMR) has been singled out by experts for deviating from clinical evidence, appearing at worst politically motivated and all too positive at best,” the publisher said.
The extra editorial read: “A letter from ICMR Director General Balram Bhargava stated that ICMR was contemplating the launch of a coronavirus vaccine on August 15 (Indian Independence Day; a deadline considered unrealistic by top medical experts; ICMR supported the hydroxychloroquine remedy despite being inadequate Evidence and press reports state that knowledge about coronavirus infection has been removed from a clinical article.
However, in the following paragraphs, the publisher valued India’s blockade by stating: “During the blocking period, tertiary care provision was greater, adding access to specialized appliances such as fans. The number of tests also increased rapidly, with India among the first to implement inventions such as cluster testing».
“India has also been at the forefront of vaccine progression and production efforts, whether through national candidate vaccines and brands such as the Serum Institute of India preparing the production capacity of evolving vaccine candidates around the world,” he added.
Already have an account? Connect
Start your 14-day loose trial. Register
Get full virtual playback of The Hindu BusinessLine, The Hindu, Frontline, Sportstar, Crossword, Epaper from The Hindu and The Hindu BusinessLine at A SINGLE REDUCED PRICE.
Gain a diverse set of knowledge from our experts in portfolio, banking, economics, environment and more.
Access Hindu Businessline content on desktops, tablets, and mobile devices.
Discover an ad-free cleaner with faster charging times.
Customize your personal tastes and get personalized advice on your interest.
In addition